Clinical trial
A Study of Mircera in Anemic Patients With Multiple Myeloma
NCT00360347 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00360347 |
|---|---|
| Title | A Study of Mircera in Anemic Patients With Multiple Myeloma |
| Official title | Open Label, Randomized, Exploratory Study to Investigate the Hemoglobin Dose-response, the Safety and the Pharmacokinetic Profile Following Subcutaneous Administration of Mircera Once Every Three Weeks to Anemic Patients With Multiple Myeloma |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | C.E.R.A. |
| Start date | Nov 29, 2001 |
| Primary completion | Apr 29, 2003 |
| Completion | Apr 29, 2003 |
| First posted | Aug 4, 2006 |
| Last update posted | Mar 1, 2018 |
| Countries | Czechia, Poland |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: